50 employees
Syndexa Pharmaceuticals develops drugs to treat metabolic diseases.
2005
$8.5M
from 1 investors over 1 rounds
Syndexa Pharmaceuticals raised $8.5M on January 5, 2012
Investors: MP Healthcare Venture Management Inc